Smoking paradox in acute coronary syndrome without st-segment elevation

被引:8
|
作者
Amor-Salamanca, Almudena [1 ]
Devesa-Cordero, Carolina [1 ]
Cuesta-Diaz, Armando [1 ]
Carmen Carballo-Lopez, Ma [1 ]
Fernandez-Ortiz, Antonio [1 ]
Garcia-Rubira, Juan C. [1 ]
机构
[1] Hosp Clin San Carlos, Inst Cardiovasc, Unidad Crit Cardiovasc, Madrid, Spain
来源
MEDICINA CLINICA | 2011年 / 136卷 / 04期
关键词
Acute coronary syndrome; Myocardial infarction; Smoking; ACUTE MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; SMOKERS PARADOX; THROMBOLYTIC THERAPY; CESSATION; MORTALITY; DISEASE; RISK; INTERVENTION; TRIAL;
D O I
10.1016/j.medcli.2010.01.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Although smoking habit is a well-known cardiovascular risk factor, it has been described that smokers admitted because of myocardial infarction have better prognosis than non smoker patients, which is known as "the smoking paradox". The purpose of our work is to investigate whether this phenomenon occurs among patients admitted because of acute coronary syndrome without ST-segment elevation (NSTACS), and which factors help to explain it. Patients and Methods: We analysed 563 consecutive patients admitted because of NSTACS on the Coronary Unit of our hospital from January 2005 to December 2006. We analysed clinic and angiographic characteristics and their relationship with in-hospital complications and prognosis. Results: 155 Patients were smokers (27,53%). Smoker patients were younger, more often male, had less risk factors, and more often had a Killip I class at admission (91.6% vs. 79.3%). They had less commonly the combined endpoint of death, reinfarction or Killip Class IV (6.5 vs 13.6%, odds ratio 0,439, confidence interval 0,218 a 0,885, P = .018). This relationship was lost after adjusting to other significant clinical and angiographic data by logistic regression. Conclusions: Our study confirms the "smoking paradox" amongst NSTACS patients, which is explained by the lower prevalence of previous myocardial infarction, diabetes or multivessel disease. It is essential to recommend quitting the smoking habit. (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:144 / 148
页数:5
相关论文
共 50 条
  • [21] Latest Advancement of Non ST-segment Elevation Acute Coronary Syndrome
    黄桂锋
    杨希立
    South China Journal of Cardiology, 2008, 9 (04) : 203 - 208
  • [22] ST-segment elevation in lead aVR in the setting of acute coronary syndrome
    Nabati, Maryam
    Emadi, Marzieh
    Mollaalipour, Maede
    Bagheri, Babak
    Nouraei, Mahmoud
    ACTA CARDIOLOGICA, 2016, 71 (01) : 47 - 54
  • [23] Clinical significance of acute coronary syndrome with transient ST-segment elevation
    Latour-Perez, J.
    Cabello, J. B.
    MEDICINA INTENSIVA, 2011, 35 (05) : 267 - 269
  • [24] Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation
    Cohen, M
    Antman, EM
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (05) : 884 - 886
  • [25] Clopidogrel effect in patients with acute coronary syndromes without ST-segment elevation
    de Prado, AP
    Fernandez-Vazquez, F
    Ramon, JCC
    Alonso-Orcajo, N
    Vicente, CP
    de Blas, RC
    Nieto, AD
    Castro, AD
    Rodriguez, DA
    Lampin, BS
    Gomez, CO
    Calabozo, RG
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 104H - 105H
  • [26] Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation
    Anchan, Rajeev
    Cifu, Adam S.
    Paul, Jonathan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1556 - 1557
  • [27] Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation
    Borja, J
    Olivella, P
    THROMBOSIS AND HAEMOSTASIS, 2002, 87 (03) : 538 - 538
  • [28] Antiplatelet Therapy in Acute Coronary Syndromes without Persistent ST-Segment Elevation
    Deepak Jain
    Hugo A. Katus
    Gert Richardt
    Cardiovascular Drugs and Therapy, 2001, 15 : 423 - 436
  • [29] Antiplatelet therapy in acute coronary syndromes without persistent ST-segment elevation
    Jain, D
    Katus, HA
    Richardt, G
    CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (05) : 423 - 436
  • [30] High-sensitivity cardiac Troponin for the Diagnosis of acute coronary syndrome without ST-segment Elevation
    Gimenez, Maria Rubini
    Boeddinghaus, Jasper
    Nestelberger, Thomas
    Twerenbold, Raphael
    Mueller, Christian Eugen
    AKTUELLE KARDIOLOGIE, 2021, 10 (02) : 112 - 119